DEVOTIDA Trademark

Trademark Overview

On Saturday, August 27, 2016, a trademark application was filed for DEVOTIDA with the United States Patent and Trademark Office. The USPTO has given the DEVOTIDA trademark a serial number of 79195696. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 5, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The DEVOTIDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
devotida

General Information

Serial Number79195696
Word MarkDEVOTIDA
Filing DateSaturday, August 27, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 5, 2024
Registration Number5357023
Registration DateTuesday, December 19, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Friday, December 9, 2016REFUSAL PROCESSED BY MPU
Thursday, November 10, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 15, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, November 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 22, 2016APPLICATION FILING RECEIPT MAILED
Friday, December 2, 2016ASSIGNED TO EXAMINER
Monday, December 5, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 17, 2017LETTER OF SUSPENSION E-MAILED
Friday, December 9, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Tuesday, January 17, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 2, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 17, 2017SUSPENSION LETTER WRITTEN
Friday, February 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 19, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, March 28, 2018FINAL DISPOSITION PROCESSED
Tuesday, August 8, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 8, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, August 26, 2017ASSIGNED TO LIE
Thursday, August 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 28, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 11, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 19, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 5, 2024CANCELLED SECTION 71

Related Keywords

devotida system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary